Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences
Woburn, Mass. – Aphios Corporation, a clinical stage biotechnology company developing therapeutics for oncology and supportive care, HIV/AIDS, and Alzheimer's disease announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 New York, NY.
The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, "With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Aphios' research and scientific insights in supportive care for cancer patients, HIV latency and Alzheimer's disease position them to make major contributions both towards disease modification and potential cure of some chronic, debilitating diseases as well as quality-of-life-improvement."
"We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to treat many chronic and debilitating diseases such as cancer, infectious diseases and central nervous system disorders afflicting populations around the world today," said Dr. Trevor P. Castor, CEO, Aphios Corporation. "We welcome the chance to interact with many of world's leading scientific minds, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world."
Cavendish Global consists of over 150 leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world. Cavendish Global together with the Global Partnerships Forum and the New York Academy of Sciences organizes the Forum annually in New York.
About Aphios Corporation
Aphios® Corporation, a clinical-stage biotechnology company, is developing enhanced therapeutics for chronic, debilitating diseases and improving quality of life. Using advanced scientific and engineering techniques, we are developing green, enabling technology platforms for improving drug discovery and manufacturing, nanotechnology drug delivery, viral vaccines, and virus-free human plasma and biologics. Based on these platforms, Aphios is developing quality-of-life medicines for health maintenance and disease prevention, and enhanced therapeutics for the treatment of certain cancers and supportive care, infectious disease such as HIV/AIDS, and CNS disorders such as Alzheimer's disease. Further information is available on the Company's website: www.aphios.com
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment, grant making and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; in the United States (taking place in New York at the United Nations Headquarters May 5th to 7th 2014), Europe (London, October 2014, in association with SV Life Sciences, hosted by Oxford University) and a third event held at a Cavendish Host Partner City which moves to a different global location each year (Dubai, UAE January 2015). For more information: http://cavendishglobal.com